Revvity Blog
Powering innovation from discovery to cure.
Latest
How conditional bispecific antibodies are advancing precision immunotherapy.
Cancer
August 14, 2025 - 2 min read
Biologics
Three productivity advantages of switching to transposon-based integration.
July 18, 2025 -
4 min read
Biologics
How to improve plasmid DNA quality control to accelerate RNA innovation.
June 6, 2025 -
3 min read
Biologics
The economic factors shaping expression system decisions and manufacturing strategies.
March 24, 2025 -
3 min read
Biologics
Trends and innovations: new insights from the 2024 bioprocessing summit (BPS) and bioprocess international (BPI) conferences.
November 4, 2024 -
3 min read
Biologics
White paper: screening and characterization of multi-specific antibody therapeutics.
June 24, 2024 -
2 min read
Biologics
Offsetting COVID-19 staffing limitations in a laboratory: improving workflow efficiency via shorter assay workflows.
June 24, 2024 -
3 min read
Biologics
Challenges and strategies for characterization of next-generation bispecific antibodies.
May 24, 2024 -
3 min read